Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease
Risankizumab noninferior for clinical remission at week 24, superior for endoscopic remission at week 48
Odds of IBS, Functional Dyspepsia Increased After Acute Gastroenteritis Episode
Significantly increased odds seen for irritable bowel syndrome, functional dyspepsia compared with nonexposed controls
More Women Than Men Experience Nonphysical Violence in Health Care Workforce
Women more likely to experience verbal abuse, sexual harassment, bullying, while men more likely to experience physical violence
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
Initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage
Postpandemic Physician Revenue Recovery Varies by Specialty, Practice Type
Pathology, psychiatry revenue experienced robust recovery by 2022; surgery, oncology revenue remained at or below baseline
Improved GERD Questionnaire Scores Seen With Antireflux Mucosectomy
Authors say antireflux mucosectomy should be primarily considered in patients with severe, refractory symptoms
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
Significantly lower risk of major adverse cardiovascular events, all-cause mortality seen in metabolic surgery group
Histologic Response Up With Benralizumab for Eosinophilic Esophagitis
Significantly more patients had histologic response with benralizumab than placebo, but no significant difference seen in dysphagia symptoms
Dupilumab Ups Histologic Response for Pediatric Eosinophilic Esophagitis
Significant improvements seen in histologic, endoscopic, and transcriptomic measures in higher-exposure dupilumab regimen
PIK3CA Could Guide Use of COX-2 Inhibitors in Treatment for Colon Cancer
Patients with stage III resected colon cancer with PIK3CA gain-of-function mutations treated with celecoxib had improved DFS, OS
